High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Blood Adv (in press)
DOI 10.1182/bloodadvances.2025016651, PubMed 40674706
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer
Breast Cancer Res, 27 (1), 131
DOI 10.1186/s13058-025-02082-x, PubMed 40660361
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
Br J Cancer (in press)
DOI 10.1038/s41416-025-03095-1, PubMed 40659859